Life Science Leader Magazine Supplements

CMO Leadership Awards 2013

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/183480

Contents of this Issue

Navigation

Page 29 of 69

OUTSOURCING INSIGHTS OUTSOURCING INSIGHTS By Victor Coker, director of business intelligence, That's Nice LLC CROs provide independent development services for the procurement staff, it is important to share the outsourcing pharmaceutical and biotechnology is working toward objectives and goals so that everyonemarkets. CROs have evolved purpose. Laying support, to providing wide the same from offering basic the foundation for a a true range of clinical, central laboratory, an analytical services collaboration, which contributes to and environment of that meet the is where long-term savings will develop. mutual giving, present demand of the market and its sponsors. Currently, smaller CROs are consolidating (as defined by revenue market shares) and, coupled with acquisitions, are expanding and adding new services. As a result, there is a build up in early-stage research segments, creating a downward pull on growth rates and a severely price sensitive marketplace. Many management teams within these CROs have simply focused on pricing structure as a primary lever to sustain growth and encourage brand awareness amidst the current constrictive economic conditions. To investigate the validity of this business practice, we reviewed the Brand Index data from the recently released Nice Insight Contract Research and Manufacturing (CRAMS) report. First, we identified the top 10 CROs of which our survey respondents were most familiar — respondents indicated they either know the company well and/or have worked with the company. The companies were as follows (in no particular order): ICON (Prevalere Life Science), Lancaster Laboratories, Millipore, Huntingdon Life Sciences, Nanosyn, Boston Analytical, on CMOs EMD Then, it is time to seek out information Covance, to see Chemicals, West Pharmaceutical Services, and Capsugel.with which companies may align with those goals. Start We found that the top 10 companies rated similarly on investigating how the company is perceived in quality, the perception of pricing; however, this close match and reliability, regulatory track record, productivity, in rankings did not transfer over to brand awareness. For innovation. example, Lancaster Laboratories and Capsugel aligned closely in pricing, rating 5.5 and 5.8 out of 10, respectively. In terms of awareness, however, 42 percent of respondents indicated they were either familiar with or had worked with Lancaster Laboratories, whereas only 20 percent indicated the same of Capsugel. This means that pricing structure alone is not an indicator of brand growth or recognition. Most management teams within the CRAMS industry view marketing as simply a support function to sales, instead of a tool to increase awareness among current and potential customers. Understandably, the problem of establishing an adequate benchmark for marketing ROI can make it a daunting investment. However, our observations from the Brand Index data indicate that the companies with the highest awareness — and thus the most productive pipelines — are those communicating a differentiated value to the appropriate target audience. It follows that the ability to leverage the product or services of an organization through targeted marketing could significantly improve lead generation. Survey Methodology: The Nice Insight Pharmaceutical and Biotechnology Survey is deployed to outsourcing-facing pharmaceutical and biotechnology executives. The 2012-2013 report includes responses from 10,036 participants. The survey comprises 500+ questions and randomly presents ~30 questions to each respondent in order to collect baseline information with respect to customer awareness and customer perceptions on the top 100+ CMOs and top 50+ CROs servicing the drug development cycle. Over 900 marketing communications, including branding, websites, print advertisements, corporate literature, and trade show booths are reviewed by our panel of respondents. Five levels of awareness from "I've never heard of them" to "I've worked with them" factor into the overall customer awareness score. The customer perception score is based on six drivers in outsourcing: Quality, Innovation, Regulatory Track Record, Affordability, Productivity, and Reliability. If you want to learn more about the report or how to participate, please contact Nigel Walker, managing director, or Salvatore Fazzolari, director of client services, at Nice Insight by sending an email to niceinsight.survey@thatsnice.com. Walker 28 The CMO Leadership Awards 2013

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO Leadership Awards 2013